AU2002224063A1 - Water-soluble liquid internal medicine - Google Patents

Water-soluble liquid internal medicine

Info

Publication number: AU2002224063A1
Authority: AU; Australia
Prior art keywords: water; internal medicine; soluble liquid; liquid internal; soluble
Prior art date: 2000-11-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002224063A

Inventor

Nobuyoshi Furuya

Yoshimi Hashimoto

Haruyoshi Kojima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yamanouchi Pharmaceutical Co Ltd

Original Assignee

Yamanouchi Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-24

Filing date

2001-11-21

Publication date

2002-06-03

2001-11-21 Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd

2002-06-03 Publication of AU2002224063A1 publication Critical patent/AU2002224063A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002224063A 2000-11-24 2001-11-21 Water-soluble liquid internal medicine Abandoned AU2002224063A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-357701		2000-11-24
JP2000357701		2000-11-24
PCT/JP2001/010175 WO2002041892A1 (en)	2000-11-24	2001-11-21	Water-soluble liquid internal medicine

Publications (1)

Publication Number	Publication Date
AU2002224063A1 true AU2002224063A1 (en)	2002-06-03

Family

ID=18829719

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002224063A Abandoned AU2002224063A1 (en)	2000-11-24	2001-11-21	Water-soluble liquid internal medicine

Country Status (8)

Country	Link
US (1)	US20040039036A1 (en)
EP (1)	EP1336408A4 (en)
JP (1)	JP4388743B2 (en)
KR (1)	KR100765026B1 (en)
CN (1)	CN100453079C (en)
AU (1)	AU2002224063A1 (en)
CA (1)	CA2426925A1 (en)
WO (1)	WO2002041892A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2003094889A1 (en) *	2002-05-13	2005-10-13	第一製薬株式会社	Freeze-dried product
JP2006063014A (en) *	2004-08-26	2006-03-09	Kowa Co	Treatment of peptic ulcer and prevention of recurrence
WO2018154495A1 (en) *	2017-02-24	2018-08-30	Ftf Pharma Private Limited	Pharmaceutical composition of oral solution of muscarinic antagonist
USD877140S1 (en)	2018-02-01	2020-03-03	Hewlett-Packard Development Company, L.P.	Computer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58103312A (en) *	1981-12-15	1983-06-20	Yamanouchi Pharmaceut Co Ltd	Aqueous solution for injection of hardly soluble drug and its preparation
DE4322826A1 (en) *	1993-07-08	1995-01-12	Galenik Labor Freiburg Gmbh	Pharmaceutical preparation
US5650421A (en) *	1995-03-31	1997-07-22	Baxter International Inc.	Premixed famotidine formulation
US5653987A (en) *	1995-05-16	1997-08-05	Modi; Pankaj	Liquid formulations for proteinic pharmaceuticals
US5759539A (en) *	1995-06-06	1998-06-02	Georgia Research Foundation, Inc.	Method for rapid enzymatic alcohol removal
JPH0952827A (en) *	1995-06-09	1997-02-25	Taisho Pharmaceut Co Ltd	Oral composition
FR2740686B1 (en) *	1995-11-03	1998-01-16	Sanofi Sa	STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION
JP3213283B2 (en) *	1997-10-16	2001-10-02	山之内製薬株式会社	Injection
JP3285198B2 (en) *	1998-06-12	2002-05-27	藤沢薬品工業株式会社	Liquid for internal use
WO2001056547A2 (en) *	2000-02-04	2001-08-09	Seo Hong Yoo	Preparation of aqueous clear solution dosage forms with bile acids

2001
- 2001-11-21 CN CNB018195032A patent/CN100453079C/en not_active Expired - Fee Related
- 2001-11-21 US US10/432,325 patent/US20040039036A1/en not_active Abandoned
- 2001-11-21 JP JP2002544070A patent/JP4388743B2/en not_active Expired - Fee Related
- 2001-11-21 KR KR1020037006974A patent/KR100765026B1/en not_active Expired - Fee Related
- 2001-11-21 CA CA002426925A patent/CA2426925A1/en not_active Abandoned
- 2001-11-21 WO PCT/JP2001/010175 patent/WO2002041892A1/en not_active Ceased
- 2001-11-21 AU AU2002224063A patent/AU2002224063A1/en not_active Abandoned
- 2001-11-21 EP EP01997305A patent/EP1336408A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
CN1476327A (en)	2004-02-18
KR100765026B1 (en)	2007-10-09
CA2426925A1 (en)	2003-04-25
JP4388743B2 (en)	2009-12-24
US20040039036A1 (en)	2004-02-26
EP1336408A4 (en)	2005-01-19
CN100453079C (en)	2009-01-21
WO2002041892A1 (en)	2002-05-30
EP1336408A1 (en)	2003-08-20
JPWO2002041892A1 (en)	2004-03-25
KR20040012685A (en)	2004-02-11

Publication	Publication Date	Title
AU2002220268A1 (en)	2002-05-06	Anti-drawback medical valve
AU2001269529A1 (en)	2002-01-30	Medicine comprising dicyanopyridine derivative
AU2001264887A1 (en)	2001-12-03	Drug delivery device
AU2002232422A1 (en)	2002-05-27	Pump and diaphragm for use therein
AU2001296870A1 (en)	2002-07-01	Fluid injection device
AU2001238137A1 (en)	2001-08-20	Communicating device
AU2001256023A1 (en)	2001-11-12	Fracturing fluid
AU2001274548A1 (en)	2002-01-02	Syringe
AUPR045600A0 (en)	2000-10-26	Fluid devices
AU2001248833A1 (en)	2001-11-07	Stable liquid preparation
AU2001224818A1 (en)	2002-07-18	Device for administering liquids
AU2002221099A1 (en)	2002-06-18	Combination drugs
AUPQ761100A0 (en)	2000-06-08	Lipophilic medicament
AU2001227084A1 (en)	2001-08-07	N-arylhydrazide compounds and use thereof as drugs
AU2001270749A1 (en)	2002-01-08	Delivery device
AU2001232244A1 (en)	2001-08-20	Drug comprising combination
AU2001256714A1 (en)	2001-11-26	Water-based liquid preparation
AU2001260236A1 (en)	2001-11-07	Restricted use syringe
AU2002224063A1 (en)	2002-06-03	Water-soluble liquid internal medicine
AUPQ974300A0 (en)	2000-09-21	Fluid delivery system
AU2001287435A1 (en)	2002-03-13	Fracturing fluid
AU2001244854A1 (en)	2001-10-03	Local drug delivery
AU5243501A (en)	2001-11-12	Fluid delivery device
AU2001282349A1 (en)	2002-03-04	Fluid treatment
AU2001292578A1 (en)	2002-04-15	Pharmaceutical compounds